Edition:
United States

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

11.82USD
4:00pm EDT
Change (% chg)

$0.12 (+1.03%)
Prev Close
$11.70
Open
$11.70
Day's High
$11.92
Day's Low
$11.57
Volume
40,511
Avg. Vol
71,389
52-wk High
$11.99
52-wk Low
$0.96

Chart for

About

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene... (more)

Overall

Beta: 0.38
Market Cap(Mil.): $412.81
Shares Outstanding(Mil.): 35.28
Dividend: --
Yield (%): --

Financials

  CDNA.OQ Industry Sector
P/E (TTM): 34.94 236.60 32.60
EPS (TTM): 0.33 -- --
ROI: 29.28 -7.50 12.74
ROE: 56.74 -10.27 14.66

BRIEF-CareDx Reports Q1 Loss Per Share $0.30

* FOR FULL YEAR 2018, CAREDX EXPECTS REVENUE TO BE IN RANGE OF $64 MILLION TO $66 MILLION Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina

* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING

May 08 2018

BRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC Filing

* CAREDX SAYS ON APRIL 17 ENTERED INTO A CREDIT AGREEMENT AND GUARANTY - SEC FILING

Apr 18 2018

BRIEF-Caredx Launches Heartcare For Heart Transplant Recipients

* ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS Source text for Eikon: Further company coverage:

Apr 10 2018

BRIEF-CareDx Q4 Non-Gaap Loss Per Share $0.09

* FY2018 REVENUE VIEW $61.5 MILLION -- THOMSON REUTERS I/B/E/S

Mar 22 2018

BRIEF-Caredx - Entered Binding Commitment With Perceptive Advisors For Term Loan Of Between $15 Mln And $35 Mln

* CAREDX - ENTERED BINDING COMMITMENT WITH PERCEPTIVE ADVISORS FOR A TERM LOAN OF BETWEEN $15 MILLION AND $35 MILLION

Mar 01 2018

BRIEF-Caredx Sees FY 2017 Revenue $48.1 Mln To $48.3 Mln

* CAREDX REPORTS PRELIMINARY FOURTH QUARTER AND FY2017 FINANCIAL RESULTS

Jan 08 2018

Competitors

Earnings vs. Estimates